[1]张向荣, 刘德伍, 郭光华. 骨髓间充质干细胞生物学特性及其在组织修复中的应用. 中国组织工程研究与临床康复, 2008, 12(8): 1513-1516.Zhang X R, Liu D W, Guo G H. Biological characteristics of mesenchymal stem cells and its application in tissue repair. Journal of Clinical Rehabilitative Tissue Engineering Research, 2008, 12(8): 1513-1516. (in Chinese)[2]Liu G L, Lu Y F, Li W J, Xiao H Z, Sun G G, Yu F, Xiang X X, Zhang H Q, Liu X L, Shi Y P, Li S. Differentiation of marrow-derived islet-like cells and their effects on diabetic rats. Chinese Medical Journal, 2010, 123(22): 3347-3350.[3]Wang J C, Xia L, Song X B, Wang C E, Wei F C. Transplantation of hypoxia preconditioned bone marrow mesenchymal stem cells improves survival of ultra-long random. Chinese Medical Journal, 2011, 124(16): 2507-2511.[4]Chang Q, Yan L, Wang C Z, Zhang W H, Hu Y Z, Wu B Y. In vivo transplantation of bone marrow mesenchymal stem cells accelerates repair of injured gastric mucosa in rats. Chinese Medical Journal, 2012, 125(6): 1169-1174.[5]Friedenstein A J, Piatetzky S II, Petrakova K V. Osteogenesis in transplants of bone marrow cells. Journal of Embryology and Experimental Morphology, 1966, 16(3): 381-390.[6]Rossignol J, Boyer C, Thinard R, Remy S, Dugast A S, Dubayle D, Dey N D, Boeffard F, Delecrin J, Heymann D, Vanhove B, Anegon I, Naveilhan P, Dunbar G L, Lescaudron L. Mesenchymal stem cells induce a weak immune response in the rat striatum after allo or xenotransplantation. Journal of Cellular and Molecular Medicine, 2009, 13(8): 2547-2558. [7]Shi Y F, Su J J, Roberts A I, Shou P, Rabson A B, Ren G W. How mesenchymal stem cells interact with tissue immune responses. Trends in Immunology, 2012, 33(3): 136-143.[8]Yan Z Q, Hang D H, Guo C G, Chen Z R. Fate of mesenchymal stem cells transplanted to osteonecrosis of femoral head. Journal of Clinical Orthopaedics, 2009, 27(4): 442-446.[9]Wang B L, Sun W, Shi Z C, Zhang N F, Yue D B, Guo W S, Xu S Q, Lou J N, Li Z R. Treatment of nontraumatic osteonecrosis of the femoral head with the implantation of core decompression and concentrated autologous bone marrow containing mononuclear cells. Archives of Orthopaedic and Trauma Surgery, 2010, 130(7): 859-865. [10]季卫锋, 丁伟航, 马镇川, 厉驹, 童培建. 三通道髓芯钻孔减压加DBM、自体骨髓干细胞治疗早期股骨头坏死. 中国骨伤, 2008, 21(10): 776-778.Ji W F, Ding W H, Ma Z C, Li J, Tong P J. Three-tunnels core decompression with implantation of bone marrow stromal cells(bMSCs) and decalcified bone matrix (DBM) for the treatment of early femoral head necrosis. China Journal of Orthopaedics and Traumatology, 2008, 21(10): 776-778. (in Chinese)[11]Kadiyala S, Young R G, Thiede M A, Bruder S P. Culture expanded canine mesenchymal stem cells possess osteochondrogenic potential in vivo and in vitro. Cell Transplant, 1997, 6(2): 125-134.[12]Yoshikawa H,Taniguchi S I, Yamamura H, Mori S, Sugimoto M, Miyado K, Nakamura K, Nakao K, Katsuki M, Shibata N, Takahashi K. Mice lacking smooth muscle calponin display increased bone formation that is associated with enhancement of bone morphogenetic protein responses. Genes to Cells, l998, 3: 685-695.[13]Livak K J, Schmittgen T D. Analysis of relative gene expression data using real-time quantitative PCR and the 2− ΔΔCT method. Methods, 2001, 25(4): 402-408.[14]Zhao Y M, Waldman S D, Flynn L E. The effect of serial passaging on the proliferation and differentiation of bovine adipose-derived stem cells. Cells Tissues Organs, 2012, 195(5): 414-427.[15]Jackson W M, Nesti L J, Tuan R S. Potential therapeutic applications of muscle-derived mesenchymal stem and progenitor cells. Expert Opinion on Biological Therapy, 2010, 10(4): 505-517.[16]Tobiasch E. Adult human msenchymal stem cells as source for future tissue engineering. Forschungsspitzen and Spitzenforschung, 2009: 329-338.[17]Bruno S, Bussolati B, Grange C, Collino F, Cantogno L V, Herrera M B, Biancone L, Tetta C, Segoloni G, Camussi G. Isolation and characterization of resident mesenchymal stem cells in human glomeruli. Stem Cells and Development, 2009, 18(6): 867-880.[18]Secco M, Zucconi E, Vieira N M, Fogaca L L Q¸ Cerqueira A, Carvalho M D F, Jazedje T, Okamoto O K, Muotri A R, Zatz M. Multipotent stem cells from umbilical cord: cord is richer than blood! Stem Cells, 2008, 26: 146-150.[19]Zhao J J, Chen N Y, Shen N, Zhao H, Wang D L, Shi J, Wang Y, Cui X F, Yan Z Y, Xue H. Transplantation of human umbilical cord blood mesenchymal stem cells to treat a rat model of raumatic brain injury. Neural Regeneration Research, 2012, 7(10): 741-748.[20]Lee J M, Jung J, Lee H J, Jeong S J, Cho K J, Hwang S G, Kim G J. Comparison of immunomodulatory effects of placenta mesenchymal stem cells with bone marrow and adipose mesenchymal stem cells. International Immunopharmacology, 2012, 13(2): 219-224.[21]Zheng H, Guo Z, Ma Q, Jia H, Dang G. Cbfa1/ osf2 transduced bone marrow stromal cells facilitate bone formation in vitro and in vivo. Calcified Tissue International, 2004, 74: 194-203.[22]Komori T. Runx2, a multifunctional transcription factor in skeletal development. Journal of Cellular Biochemistry, 2002, 87(1): 1-8.[23]Xuan D Y, Sun X, Yan Y X, Xie B Y, Xu P P, Zhang J C. Effect of cleidocranial dysplasia-related novel mutation of RUNX2 on characteristics of dental pulp cells and tooth. Journal of Cellular Biochemistry, 2010, 111: 1473-1481.[24]Michael Cohen Jr M. Perspectives on RUNX genes: an update. American Journal of Medical Genetics, 2009, 149A: 2629-2646.[25]Lu Y B, Li Y C, Cavender A C, Wang S Z, Mansukhani A, D’Souza1 R N. Molecular studies on the roles of Runx2 and Twist1 in regulating FGF signaling. Developmental Dynamics, 2012, 241: 1708-1715.[26]Lien C Y, Lee O K, Su Y. Cbfb enhances the osteogenic differentiation of both human and mouse mesenchymal stem cells induced by Cbfa‐1 via reducing its ubiquitination‐mediated degradation. Stem Cells, 2007, 25(6): 1462-1468.[27]Tran T C, Kimura K, Nagano M, Yamashita T, Ohneda K, Sugimori H, Sato F, Sakakibara Y, Hamada H, Yoshikawa H, Hoang S N, Ohneda O. Identification of human placenta-derived mesenchymal stem cells involved in re-endothelialization. Journal of Cellular Physiology, 2011, 226(1): 224-235.[28]Strasser P, Gimona M, Moessler H, Herzog M, Small J V. Mammalian calponin: identification and expression of genetic variants. FEBS Letters, 1993, 330(1): 13-18.[29]Shibukawa Y, Yamazaki N, Kumasawa K, Daimon E, Tajiri M, Okada Y, Ikawa M, Wada Y. Calponin 3 regulates actin cytoskeleton rearrangement in trophoblastic cell fusion. Molecular Biology of the Cell, 2010, 21(15): 3973-3984.[30]王书美, 张连峰. 碱性调宁蛋白的研究进展. 中国比较医学杂志, 2010, 20(1): 57-60.Wang S M, Zhang L F. Advances on basic calponin. Chinese Journal of Comparative Medicine, 2010, 20(1): 57-60. (in Chinese)[31]Su N, Chen M M, Chen S Y, Li C, Xie Y L, Zhu Y, Zhang Y Z, Zhao L, He Q F, Du X L, Chen D, Chen L. Overexpression of h1calponin in osteoblast lineage cells leads to a decreased in bone mass by disrupting osteoblast function and promoting osteoclast formation. Journal of Bone and Mineral Research, doi:[10.1002/jbmr.1778] |